BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29431186)

  • 1. Trogocytosis of ligand-receptor complex and its intracellular transport in CD30 signalling.
    Nakashima M; Watanabe M; Uchimaru K; Horie R
    Biol Cell; 2018 May; 110(5):109-124. PubMed ID: 29431186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protrusion-guided extracellular vesicles mediate CD30 trans-signalling in the microenvironment of Hodgkin's lymphoma.
    Hansen HP; Engels HM; Dams M; Paes Leme AF; Pauletti BA; Simhadri VL; Dürkop H; Reiners KS; Barnert S; Engert A; Schubert R; Quondamatteo F; Hallek M; Pogge von Strandmann E
    J Pathol; 2014 Mar; 232(4):405-14. PubMed ID: 24659185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD30 on extracellular vesicles from malignant Hodgkin cells supports damaging of CD30 ligand-expressing bystander cells with Brentuximab-Vedotin, in vitro.
    Hansen HP; Trad A; Dams M; Zigrino P; Moss M; Tator M; Schön G; Grenzi PC; Bachurski D; Aquino B; Dürkop H; Reiners KS; von Bergwelt-Baildon M; Hallek M; Grötzinger J; Engert A; Paes Leme AF; Pogge von Strandmann E
    Oncotarget; 2016 May; 7(21):30523-35. PubMed ID: 27105521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autocrine growth regulation of CD30 ligand in CD30-expressing Reed-Sternberg cells: distinction between Hodgkin's disease and anaplastic large cell lymphoma.
    Hsu PL; Hsu SM
    Lab Invest; 2000 Jul; 80(7):1111-9. PubMed ID: 10908157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mast cells express functional CD30 ligand and are the predominant CD30L-positive cells in Hodgkin's disease.
    Molin D; Fischer M; Xiang Z; Larsson U; Harvima I; Venge P; Nilsson K; Sundström C; Enblad G; Nilsson G
    Br J Haematol; 2001 Sep; 114(3):616-23. PubMed ID: 11552987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD30 ligand, a member of the TNF ligand superfamily, with growth and activation control CD30+ lymphoid and lymphoma cells.
    Gruss H-J ; Herrmann F
    Leuk Lymphoma; 1996 Feb; 20(5-6):397-409. PubMed ID: 8833395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD30 activates both the canonical and alternative NF-kappaB pathways in anaplastic large cell lymphoma cells.
    Wright CW; Rumble JM; Duckett CS
    J Biol Chem; 2007 Apr; 282(14):10252-62. PubMed ID: 17261581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD30 ligand expression in nonmalignant and Hodgkin's disease-involved lymphoid tissues.
    Gruss HJ; Pinto A; Gloghini A; Wehnes E; Wright B; Boiani N; Aldinucci D; Gattei V; Zagonel V; Smith CA; Kadin ME; von Schilling C; Goodwin RG; Herrmann F; Carbone A
    Am J Pathol; 1996 Aug; 149(2):469-81. PubMed ID: 8701986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and regulation of CD30 ligand and CD30 in human leukemia-lymphoma cell lines.
    Gruss HJ; DaSilva N; Hu ZB; Uphoff CC; Goodwin RG; Drexler HG
    Leukemia; 1994 Dec; 8(12):2083-94. PubMed ID: 7528856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD30 ligand is frequently expressed in human hematopoietic malignancies of myeloid and lymphoid origin.
    Gattei V; Degan M; Gloghini A; De Iuliis A; Improta S; Rossi FM; Aldinucci D; Perin V; Serraino D; Babare R; Zagonel V; Gruss HJ; Carbone A; Pinto A
    Blood; 1997 Mar; 89(6):2048-59. PubMed ID: 9058727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD30 ligand in lymphoma patients with CD30+ tumors.
    Younes A; Consoli U; Snell V; Clodi K; Kliche KO; Palmer JL; Gruss HJ; Armitage R; Thomas EK; Cabanillas F; Andreeff M
    J Clin Oncol; 1997 Nov; 15(11):3355-62. PubMed ID: 9363866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human eosinophils express functional CD30 ligand and stimulate proliferation of a Hodgkin's disease cell line.
    Pinto A; Aldinucci D; Gloghini A; Zagonel V; Degan M; Improta S; Juzbasic S; Todesco M; Perin V; Gattei V; Herrmann F; Gruss HJ; Carbone A
    Blood; 1996 Nov; 88(9):3299-305. PubMed ID: 8896393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD30 ligand signal transduction involves activation of a tyrosine kinase and of mitogen-activated protein kinase in a Hodgkin's lymphoma cell line.
    Wendtner CM; Schmitt B; Gruss HJ; Druker BJ; Emmerich B; Goodwin RG; Hallek M
    Cancer Res; 1995 Sep; 55(18):4157-61. PubMed ID: 7545087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and expression of a soluble form of human CD30 ligand with functional activity.
    Powell IF; Li T; Jäck HM; Ellis TM
    J Leukoc Biol; 1998 Jun; 63(6):752-7. PubMed ID: 9620669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD30 ligand (CD30L)-expressing acute myeloid leukemias: a new model of paracrine interactions for the regulation of blast cells proliferation.
    Gattei V; Degan M; Rossi FM; de Iuliis A; Mazzocco FT; Serraino D; Zagonel V; Aldinucci D; Pinto A
    Leuk Lymphoma; 1999 Sep; 35(1-2):21-35. PubMed ID: 10512160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferation of CD30+ T-helper 2 lymphoma cells can be inhibited by CD30 receptor cross-linking with recombinant CD30 ligand.
    Willers J; Dummer R; Kempf W; Kündig T; Burg G; Kadin ME
    Clin Cancer Res; 2003 Jul; 9(7):2744-54. PubMed ID: 12855655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant CD30 ligand and CD40 ligand share common biological activities on Hodgkin and Reed-Sternberg cells.
    Gruss HJ; Ulrich D; Braddy S; Armitage RJ; Dower SK
    Eur J Immunol; 1995 Jul; 25(7):2083-9. PubMed ID: 7621881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human angiogenin fused to human CD30 ligand (Ang-CD30L) exhibits specific cytotoxicity against CD30-positive lymphoma.
    Huhn M; Sasse S; Tur MK; Matthey B; Schinköthe T; Rybak SM; Barth S; Engert A
    Cancer Res; 2001 Dec; 61(24):8737-42. PubMed ID: 11751393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD30 Expression and Its Functions during the Disease Progression of Adult T-Cell Leukemia/Lymphoma.
    Nakashima M; Uchimaru K
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deciphering CD30 ligand biology and its role in humoral immunity.
    Kennedy MK; Willis CR; Armitage RJ
    Immunology; 2006 Jun; 118(2):143-52. PubMed ID: 16771849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.